Clinical evaluation of sintilimab in conjunction with bevacizumab for advanced colorectal cancer with microsatellite stable-type after failure of first-line therapy

doi:10.4240/wjgs.v16.i10.3277

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 16, Issue 10

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (1517)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-3) series, Tables (1-4) series.

Item

Count

PDF

HTML

951

Figures (1-3)

140

Tables (1-4)

148

Sum=1276

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

Download

143

Sum=200

Oct 27, 2024 (publication date) through Feb 14, 2025

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Gastrointestinal Surgery

ISSN

1948-9366

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Randomized Controlled Trial

World J Gastrointest Surg. Oct 27, 2024; 16(10): 3277-3287
Published online Oct 27, 2024. doi: 10.4240/wjgs.v16.i10.3277

Full Size Figure Download Figure

Figure 2 Comparison of short-term survival stations between the two groups. The progression-free survival of the experimental participants was markedly prolonged relative to the controls. PFS: Progression-free survival.

Citation: Wang L, Diao YZ, Ma XF, Luo YS, Guo QJ, Chen XQ. Clinical evaluation of sintilimab in conjunction with bevacizumab for advanced colorectal cancer with microsatellite stable-type after failure of first-line therapy. World J Gastrointest Surg 2024; 16(10): 3277-3287
URL: https://www.wjgnet.com/1948-9366/full/v16/i10/3277.htm
DOI: https://dx.doi.org/10.4240/wjgs.v16.i10.3277